Selected Grants
Development of Diagnostic/Therapeutic Agents Targeting Borrelia burgdorferi HtpG
ResearchSenior Research Scientist · Awarded by Department of Defense · 2024 - 2027Development of an oral targeted drug for treatment of bartonelloses
ResearchSenior Research Scientist · Awarded by Steven & Alexandra Cohen Foundation · 2021 - 2025Preclinical Development Of Novel Borrelia Sp. Targeting Therapeutic And Diagnostic Imaging Agents.
ResearchSenior Research Scientist · Awarded by Bay Area Lyme Foundation · 2021 - 2025Detection and Elimination of Oncogenic Signaling Networks in Pre-malignant and Malignant Cells with Magnetic Resonance Imaging
ResearchCo Investigator · Awarded by Department of Defense · 2012 - 2022Improving the Oral Bioavailability and In vivo Efficacy of the TAK 1 Inhibitor, Takinib.
ResearchResearch Scientist · Awarded by Eydis Bio Inc. · 2019 - 2021An orally bioavailable broad-spectrum Hsp90 inhibitor (Hsp90i) therapy to suppress emerging Coronavirus (CoV) infections
ResearchResearch Scientist · Awarded by Good Ventures Foundation · 2020 - 2021External Relationships
- Eydis Bio, Inc.
- Innovasyn, LLC
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.